江波龍(301308.SZ):公司對企業級存儲業務的未來發展具備較強的信心
格隆匯7月18日丨有投資者向江波龍(301308.SZ)提問:公司在信創市場具備的優勢?以及現有團隊的優勢?
江波龍回覆:首先,公司重視信創行業,並採取穩紮穩打的發展戰略,從 2020年開始組建研發團隊,建設上海研發總部,主要聚焦於企業級及工規級高端存儲器的研發。其次,從產品力來看,企業級服務器對於產品本身的性能要求非常高,經過多年的技術積累,公司具備了較強的技術優勢。從研發團隊來看,公司的核心研發骨幹具備企業級服務器產品端到端的成功項目經驗及技術。綜合上述優勢,公司對企業級存儲業務的未來發展具備較強的信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.